Pharmaco-Imagery and Theranostic Agents (Q3694905): Difference between revisions
Jump to navigation
Jump to search
(Changed label, description and/or aliases in en: translated_label) |
(Changed an Item: Edited by the beneficiary bot - attach the beneficiary based on the string) |
||
| Property / beneficiary | |||
| Property / beneficiary: Q3772056 / rank | |||
Normal rank | |||
Revision as of 17:37, 24 November 2021
Project Q3694905 in France
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Pharmaco-Imagery and Theranostic Agents |
Project Q3694905 in France |
Statements
187,989.0 Euro
0 references
457,614.57 Euro
0 references
41.08 percent
0 references
30 March 2015
0 references
30 September 2017
0 references
Université de Bourgogne
0 references
Le développement de nouveaux médicaments est un processus de plus en plus coûteux et compliqué sur le plan réglementaire comme technique; l’imagerie médicale dans ce contexte représente un axe stratégique pour l’économie. (French)
0 references
The development of new drugs is an increasingly costly and technically complicated regulatory process; medical imaging in this context is a strategic focus for the economy. (English)
22 November 2021
0 references
Identifiers
BG0003226
0 references